Clinical Trials
16 trialsNCT06632327 2026-06-02
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT06114108 2026-04-02
salVage
Swiss Cancer Institute
Phase NA Recruiting
NCT06918132 2026-02-24
N-PLANC
Mayo Clinic
Phase 2 Recruiting
NCT06810609 2026-01-27
InDuRanS
University Hospital, Bonn
Phase 2 Recruiting
NCT07073365 2025-12-30
BOOST
Pusan National University Hospital
Phase 2 Recruiting
NCT07264647 2025-12-04
Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
Fondazione Ricerca Traslazionale
Phase 2 Recruiting
NCT06617936 2025-07-15
Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.
Shandong Public Health Clinical Center
Phase 2 Recruiting
NCT06939127 2025-04-22
Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06911606 2025-04-04
Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)
Guangdong Provincial People's Hospital
Phase 2 Recruiting
NCT06908070 2025-04-03
CROWD
Amsterdam UMC, location VUmc
Phase 4 Recruiting
NCT06341933 2025-01-30
Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Recruiting
NCT05974475 2024-09-23
MONDRIAN
European Institute of Oncology
Recruiting
NCT05766800 2024-09-19
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Recruiting
NCT06534489 2024-08-02
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
Ruijin Hospital
Recruiting
NCT06256237 2024-05-29
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Recruiting
NCT04875585 2022-08-24
INNWOP1
Medical University Innsbruck
Phase 2 Recruiting